alphaveTATVA₹1,655.00

Tatva Chintan Pharma Chem Limited

₹ CrorePeersVISHNU JUBLCPL KIRIINDUS FOSECOIND CHEMPLASTS DDEVPLSTIK GUJALKALI YASHOMcap ₹3,871 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	426.5	525.6	604.1	604.1
+ Capital Work-in-Progress	72.9	21.5	23.3	23.3
+ Other Intangibles	0.4	3.1	5.3	5.3
+ Intangibles under Development	3.6	2.8	1.6	1.6
+ Non-current Investments	0.0	0.0	4.0	4.0
+ Other Non-current Financial Assets	4.3	4.3	5.0	5.0
Non-current Financial Assets	4.3	4.3	9.0	9.0
+ Deferred Tax Assets	12.3	12.6	9.6	9.6
+ Other Non-current Assets	0.8	1.1	1.3	1.3
Total Non-current Assets	520.8	571.0	654.2	654.2
Current Assets
+ Inventories	152.8	134.0	196.1	196.1
+ Current Investments	10.1	0.0	0.0	0.0
+ Trade Receivables	69.9	82.5	119.0	119.0
+ Cash & Cash Equivalents	35.3	11.4	5.8	5.8
+ Other Bank Balances	3.0	2.7	3.0	3.0
+ Short-term Loans	0.2	0.2	0.3	0.3
+ Other Current Financial Assets	0.7	1.1	0.4	0.4
Current Financial Assets	119.1	98.0	128.4	128.4
+ Other Current Assets	23.9	26.4	23.9	23.9
Total Current Assets	297.9	265.2	349.5	349.5
Total Assets	818.7	836.2	1,003.7	1,003.7
Equity
+ Equity Share Capital	23.4	23.4	23.4	23.4
+ Other Equity / Reserves	713.7	715.4	758.4	758.4
Equity — Owners of Parent	737.1	738.8	781.8	781.8
Total Equity	737.1	738.8	781.8	781.8
Liabilities
+ Borrowings — Non-current	0.6	0.0	5.0	5.0
Non-current Financial Liabilities	0.6	0.0	5.0	5.0
+ Provisions — Non-current	1.3	1.4	2.6	2.6
Non-current Liabilities	2.0	1.4	8.8	8.8
+ Borrowings — Current	13.6	36.4	115.4	115.4
+ Trade Payables	45.0	32.7	58.2	58.2
+ Other Current Financial Liab	8.2	5.5	12.7	12.7
Current Financial Liabilities	66.9	74.5	186.3	186.3
+ Provisions — Current	0.4	0.4	0.6	0.6
+ Current Tax Liabilities	0.1	2.0	0.3	0.3
+ Other Current Liabilities	12.3	19.0	25.8	25.8
Current Liabilities	79.7	96.0	213.1	213.1
Total Liabilities	81.6	97.4	221.9	221.9
Total Equity & Liabilities	818.7	836.2	1,003.7	1,003.7
Assets — additional as-filed lines
+ Current Tax Assets	2.1	7.0	1.1	1.1
Liabilities — additional as-filed lines
+ Deferred Government Grants — Current	0.0	0.0	0.2	0.2
+ Deferred Government Grants — Non-current	0.0	0.0	1.2	1.2
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	10.8	17.5	17.5
+ Dues to Other Creditors — Current	—	21.9	40.8	40.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.